18 and older, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Frequency of Eating in Response to Cravings (Primary Mechanistic Outcome)Primary· change from baseline to 6 months
Percent of ecological momentary assessment (EMA) opportunities in which participants reported eating in response to food cravings over a 3 day period. EMA measures were delivered to cell phones 3 times each day. The final EMA measure each day included a second question about whether there were any instances of craving related eating not already reported earlier during the day. Thus there was an opportunity to report eating in response to cravings on 4 different EMA questions each day, a total of 12 potential measures over 3 days. The percent here uses the number of EMA responses received as th
Group
Value
95% CI
Diet Education
-20.39
-28.15 – -12.62
Diet Education + Mindfulness
-25.27
-32.95 – -17.58
Change in Impulsivity as Measured by Delayed Discounting ScoreSecondary· change from baseline to 6 months
The 5-trial adaptation of the Delayed Discounting (DD; Koffarnus \& Bickel, 2014) is a decision-making exercise where individuals choose between a smaller, immediate reward and a larger, delayed reward. The task measures an individual's "discount rate," or how much they devalue a future reward compared to an immediate one, which is a a key aspect of impulsivity and self-control. Respondents choose between $100 delivered after a delay, or $50 available immediately. To derive estimates of discount rate, we used Mazur's hyperbolic discounting model (V=A/ (1+kD)18, wherein V is the discounted valu
Group
Value
95% CI
Diet Education
87.17
-38.76 – 472.03
Diet Education + Mindfulness
6.42
-63.45 – 209.89
Emotion-related Eating (Secondary Mechanistic Outcome)Secondary· change from baseline to 6 months
Change in emotion-related eating as measured by the Coping subscale of the Palatable Eating Motives Scale (PEMS). The Coping subscale is comprised of 4 items rated on a scale from 1 (almost never/never) to 5 (almost always/always), with possible scores ranging from 4-20. Higher scores reflect worse coping/greater emotional eating. Thus, decreases over time reflect improved coping/decreased emotional eating.
Group
Value
95% CI
Diet Education
-0.62
-1.00 – -0.25
Diet Education + Mindfulness
-0.90
-1.27 – -0.53
Stress-related Eating (Secondary Mechanistic Outcome)Secondary· change from baseline to 6 months
Change in stress-related eating as measured by two questions about stress-related eating from the MIDUS study. Possible scores range from 2-8. Higher scores reflect worse outcomes/greater eating in response to stress. Thus, decreases over time reflect improved outcomes/decreased stress-related eating.
Group
Value
95% CI
Diet Education
-1.62
-2.22 – -1.03
Diet Education + Mindfulness
-1.73
-2.32 – -1.15
Glycemic Control, Using HbA1cSecondary· change from baseline to 6 months
Change in hemoglobin A1c (HbA1c) from baseline to 6 months by study arm
Group
Value
95% CI
Diet Education
-1.32
-1.65 – -0.98
Diet Education + Mindfulness
-0.87
-1.20 – -0.54
Fasting GlucoseSecondary· change from baseline to 6 months
Change in plasma fasting glucose from baseline to 6 months by study arm
Group
Value
95% CI
Diet Education
-30.21
-44.48 – -15.94
Diet Education + Mindfulness
-25.92
-39.67 – -12.17
HOMA-2IR Index of Insulin Resistance (Secondary Clinical Outcome)Secondary· change from baseline to 6 months
Insulin resistance estimated from the Homeostatic model assessment (HOMA) model 2 index of insulin resistance. The basic formula is: (glucose × insulin) / 22.5, where glucose is measured in mmol/L and insulin in mU/L. The computer assisted re-calibration in model 2 addresses variations in the glucose resistance of the peripheral tissue and liver, increases in the insulin secretion curve for glucose \> 180 mg/dL, and contribution of circulating pro-insulin. Higher values indicate more insulin resistance (worse outcome). The Oxford University HOMA-2IR calculator was used (https://process.innovat
Group
Value
95% CI
Diet Education
-0.45
-0.93 – 0.02
Diet Education + Mindfulness
-0.85
-1.30 – -0.40
Weight Change(Secondary Clinical Outcome)Secondary· change from baseline to 6 months
kilograms
Group
Value
95% CI
Diet Education
-4.96
-6.44 – -3.49
Diet Education + Mindfulness
-4.43
-5.88 – -2.98
Adherence to Diet as Measured by Fingerstick Blood KetonesSecondary· 6 months
Adherence to diet as measured by average proportion of fingerstick blood ketones at or above 0.3 mmol/L at 24 weeks.
Group
Value
95% CI
Diet Education
0.46
0.26 – 0.66
Diet Education + Mindfulness
0.60
0.41 – 0.79
Diet Adherence by Mean Grams of Non-fiber Carbohydrate Consumed Per DaySecondary· change from baseline to 6 months
Diet Adherence Between Intervention Arms as Measured by Mean Grams of Non-fiber Carbohydrate Consumed Per Day From 24- Hour Diet Recall
Group
Value
95% CI
Diet Education
-91.43
-123.73 – -59.14
Diet Education + Mindfulness
-116.92
-148.53 – -85.31
Perceived StressSecondary· change from baseline to 6 months
Perceived Stress Scale (PPS-10) total score. Scores can range from 0 to 40 with higher scores indicated greater perceived stress.
Group
Value
95% CI
Diet Education
-1.09
-2.73 – 0.55
Diet Education + Mindfulness
-2.04
-3.65 – -0.44
Adverse events — posted to ClinicalTrials.gov
Time frame: 6 months.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Type 2 diabetes mellitus (T2DM) is the most expensive chronic disease in the U.S.
Lifestyle modification is central to T2DM management, but long-term adherence to dietary recommendations is difficult. A key challenge is the difficulty of coping with cravings for high carbohydrate or sugar-laden foods in an environment where these foods are tempting and widely available. One mechanism by which mindfulness may increase long-term dietary adherence is by better equipping individuals with skills to experience food cravings and difficult emotions without eating in response. Such approaches seek to strengthen abilities to be non-judgmentally aware of, tolerate, and respond skillfully to food cravings and difficult emotions without reacting impulsively or maladaptively. The investigators hypothesize that improved ability to manage food cravings and emotional eating is a key mechanism through which mindfulness-enhancements can improve dietary adherence. The study will test a mindfulness-based intervention (MBI) for improving dietary adherence. Although the particular diet employed is not the focus of this study, the study will use a diet with about 10% of calories from carbohydrate as: (1) it induces a low level of ketone production, which will be used as a biomarker for dietary adherence; (2) prior studies suggest it improves metabolic parameters in T2DM, including glycemic control.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
NCT03837405 — (R33 Phase) Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger
· NA
· completed
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2
· Phase 2
· recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part
· recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use
· NA
· recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
· Phase 1
· recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0
· recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
NCT05284773 — Screening for Acute Malnutrition
· NA
· withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling
· NA
· not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M
· Phase 1, PHASE2
· not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans
· NA
· not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT)
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 8 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03207711.